Francis Duhay - 11 Dec 2025 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Dec 2025, 21:34:33 UTC
Prior SEC filing
17 Sep 2025
Next SEC filing
13 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Francis Duhay

Key filing fact

Francis Duhay filed Form 4 for enVVeno Medical Corp (NVNO) on 15 Dec 2025.

Key facts

  • This page summarizes Francis Duhay's Form 4 filing for enVVeno Medical Corp (NVNO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 15 Dec 2025, 21:34.

Change

  • Previous filing in this sequence was filed on 17 Sep 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001760582 Primary reporting owner

Duhay Francis

Relationship
Director
Address
C/O ENVVENO MEDICAL CORPORATION,, 70 DOPPLER, IRVINE
Signature
/s/ Francis Duhay
Signature date
15 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NVNO transaction Derivative

Stock Options

Award

Transaction value
$0
Shares
+135,883
Change %
Price
$0.000000
Shares after
135,883
Date
11 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
135,883
Exercise price
$0.3250
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .